CAMBRIDGE, Mass., Jan. 2 /PRNewswire-FirstCall/ -- Millennium
Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced that its presentation
at the JPMorgan 25th Annual Healthcare Conference will be webcast live and
may be accessed by visiting the Investors section of the Company's website,
http://www.millennium.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )
Dr. Deborah Dunsire, president and chief executive officer of
Millennium, will discuss the Company's goals and financial guidance for
2007 and 2006 achievements. Her presentation will be delivered at 3:00 p.m.
PT (6:00 p.m. ET) on Monday, January 8, 2007 from the Westin St. Francis
Hotel in San Francisco, Calif. The presentation will be archived for 30
days.
About Millennium
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company
based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a
novel cancer product, and has a robust clinical development pipeline of
product candidates. The Company's research, development and
commercialization activities are focused in two therapeutic areas: oncology
and inflammation. By applying its knowledge of the human genome,
understanding of disease mechanisms and industrialized drug discovery
platform, Millennium is developing an exciting pipeline of innovative
product candidates. The Company's website is http://www.millennium.com.
Editors' Note: This press release is also available under the Media
section of the Company's website at: http://www.millennium.com.
Contact:
Kyle Kuvalanka
(617) 761-4734
SOURCE Millennium Pharmaceuticals, Inc.
 back to top
Related links:
http://www.millennium.com/
Photo Notes:http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO
AP Archive: http:
http://www.prnewswire.com/comp/114562.html /
CONTACT:
Kyle Kuvalanka, +1-617-761-4734, for
Millennium Pharmaceuticals, Inc.
|
